Using Pharmacoepidemiology To Inform Drug Coverage Policy: Initial Lessons From A Two-Province Collaborative
Author:
Publisher
Health Affairs (Project Hope)
Subject
Health Policy
Reference17 articles.
1. States’ Control Of Prescription Drug Spending: A Heterogeneous Approach
2. States’ Control Of Prescription Drug Spending: A Heterogeneous Approach
3. Centralized Drug Review Processes In Australia, Canada, New Zealand, And The United Kingdom
4. The Common Drug Review: A NICE start for Canada?
5. Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Using Pharmacoepidemiologic Studies to Inform Drug Policy and Spending: A Health Economics Perspective;Accounting, Finance, Sustainability, Governance & Fraud: Theory and Application;2023
2. Case-crossover study design in pharmacoepidemiology: systematic review and recommendations;Pharmacoepidemiology and Drug Safety;2013-09-13
3. A secure distributed logistic regression protocol for the detection of rare adverse drug events;Journal of the American Medical Informatics Association;2012-08-07
4. Impact of Drug Plan Management Policies in Canada: A Systematic Review;Canadian Pharmacists Journal / Revue des Pharmaciens du Canada;2008-11
5. Current awareness: Pharmacoepidemiology and drug safety;Pharmacoepidemiology and Drug Safety;2007
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3